101:HKEXWooyang HC Co., Ltd. Analysis

Wooyang HC is trading at 12,360 KRW, just below its 20‑day SMA of 12,411.5 KRW and marginally above the 50‑day SMA, indicating a price that is hovering near short‑term support. The MACD is bullish with a positive histogram, while the RSI sits around 50.6, suggesting neutral momentum without clear overbought or oversold conditions. Volatility is elevated at roughly 55.6% over the past 30 days, and the market sentiment index reads Extreme Greed, implying heightened speculative interest. A discounted cash flow model places the fair value near 33,047 KRW, more than double the current price, which points to a potential undervaluation from a purely financial‑model standpoint. However, the stock’s volume trend is decreasing, and the beta is slightly negative, indicating limited price responsiveness to broader market moves.
Fundamentally, the company posted a 41% revenue decline, with operating and profit margins both in negative territory, and it reports zero EPS and no dividend, highlighting earnings weakness. Despite a solid cash pile of about 36.9 bn KRW, debt remains high at roughly 25.9 bn KRW, resulting in an alarming debt‑to‑equity ratio near 13.9. The price‑to‑sales multiple of 1.6 is modest, yet the lack of earnings and high leverage raise concerns about sustainability. No analysts coverage or target prices are available, underscoring limited market visibility. Overall, the juxtaposition of a potentially attractive DCF valuation against weak profitability and high financial risk creates a mixed outlook.